403
Sorry!!
Error! We're sorry, but the page you were looking for doesn't exist.
Biovaxys Technology Corp
(MENAFN- Baystreet) 10:30 AM EST - BioVaxys Technology Corp: Announces its participation at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, taking place September 9-10, 2026, in New York City. James Passin, Chief Executive Officer, will be attending the conference, delivering an investor presentation and participating in scheduled 1-on-1 meetings with investors. BioVaxys Technology Corp
shares C are trading unchanged at $0.07.
Full Press Release:
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment